Evidence map›Paper›PMID 19074020›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2008

Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord.

Jung-Yu C Hsu, Lilly Y W Bourguignon, Christen M Adams, Karine Peyrollier, Haoqian Zhang, Thomas Fandel, Christine L Cun, Zena Werb, Linda J Noble-Haeusslein

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 142 citations in OpenAlex.

  1. Review
  2. Article
  3. A pH-responsive and self-healing CEC/PEG-(CHO)Frontiers in neuroscience · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jung-Yu C HsuDepartment of Neurological Surgery, University of California, San Francisco, California 94143, USA. jungyu.hsu@gmail.com
Lilly Y W Bourguignon
Christen M Adams
Karine Peyrollier
Haoqian Zhang
Thomas Fandel
Christine L Cun
Zena Werb
Linda J Noble-Haeusslein
University of California, San Francisco · USNeurological Surgery · USVeterans Health Administration · US

Funding

RELATIONSHIP OF PERMEABILITY BARRIER FUNCTION AND EPIDERMAL CYTOKINE PRODUCTIONP01AR039448 · NIAMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ELIAS, PETER M · 1988 to 2007
$11.8M
Vitamin D Receptor Coactivators in KeratinocytesR01AR050023 · NIAMS · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI BIKLE, DANIEL DAVID · 2004 to 2014
$3.4M
ROLE OF MATRIX METALLOPROTEINASES IN SPINAL CORD INJURYR01NS039278 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NOBLE, LINDA J. · 1999 to 2010
$3.4M
CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSIONR01CA066163 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BOURGUIGNON, LILLY YW · 1995 to 2010
$2.6M
CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSIONR01CA078633 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BOURGUIGNON, LILLY YW · 1999 to 2007
$2.5M
NCI NIH HHS R01 CA066163NCI NIH HHS R01 CA078633NIAMS NIH HHS P01 AR039448NIAMS NIH HHS R01 AR050023NINDS NIH HHS R01 NS039278
6 · The paper itself

Abstract

In the injured spinal cord, a glial scar forms and becomes a major obstacle to axonal regeneration. Formation of the glial scar involves migration of astrocytes toward the lesion. Matrix metalloproteinases (MMPs), including MMP-9 and MMP-2, govern cell migration through their ability to degrade constituents of the extracellular matrix. Although MMP-9 is expressed in reactive astrocytes, its involvement in astrocyte migration and formation of a glial scar is unknown. Here we found that spinal cord injured, wild-type mice expressing MMPs developed a more severe glial scar and enhanced expression of chondroitin sulfate proteoglycans, indicative of a more inhibitory environment for axonal regeneration/plasticity, than MMP-9 null mice. To determine whether MMP-9 mediates astrocyte migration, we conducted a scratch wound assay using astrocytes cultured from MMP-9 null, MMP-2 null, and wild-type mice. Gelatin zymography confirmed the expression of MMP-9 and MMP-2 in wild-type cultures. MMP-9 null astrocytes and wild-type astrocytes, treated with an MMP-9 inhibitor, exhibited impaired migration relative to untreated wild-type controls. MMP-9 null astrocytes showed abnormalities in the actin cytoskeletal organization and function but no detectable untoward effects on proliferation, cellular viability, or adhesion. Interestingly, MMP-2 null astrocytes showed increased migration, which could be attenuated in the presence of an MMP-9 inhibitor. Collectively, our studies provide explicit evidence that MMP-9 is integral to the formation of an inhibitory glial scar and cytoskeleton-mediated astrocyte migration. MMP-9 may thus be a promising therapeutic target to reduce glial scarring during wound healing after spinal cord injury.

Indexed as

ActinsAnimalsCell MovementCell ProliferationChondroitin Sulfate ProteoglycansCicatrixImmunohistochemistryMaleMatrix Metalloproteinase 2Matrix Metalloproteinase 9MiceNeurogliaSpinal Cord InjuriesActinsChondroitin Sulfate ProteoglycansMatrix Metalloproteinase 2Matrix Metalloproteinase 9

Identifiers

PMID19074020
PMCPMC2712293
OpenAlexW2066520425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.